IPI 145
|
|
|
- CAS-Nr.
- 1201438-56-3
- Englisch Name:
- IPI 145
- Synonyma:
- Duvelisib;IPI-14;CS-680;IPI 145;IPI-145;Duensibu;IPI-145, >=98%;IPI-145 INK197;IPI 145 USP/EP/BP;IPI-145 (INK-1197)
- CBNumber:
- CB32645143
- Summenformel:
- C22H17ClN6O
- Molgewicht:
- 416.86
- MOL-Datei:
- 1201438-56-3.mol
|
IPI 145 Eigenschaften
- Schmelzpunkt:
- 205-206o C
- Siedepunkt:
- 757.8±60.0 °C(Predicted)
- Dichte
- 1.474±0.06 g/cm3(Predicted)
- storage temp.
- -20°C
- L?slichkeit
- Soluble in DMSO (up to at least 25 mg/ml)
- Aggregatzustand
- White solid.
- pka
- 10.05±0.10(Predicted)
- Farbe
- White
- Stabilit?t:
- Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
| Bildanzeige (GHS) |
|
| Alarmwort |
Achtung |
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H360 |
Kann die Fruchtbarkeit beeintr?chtigen oder das Kind im Mutterleib sch?digen. |
Fertility (Fruchtbarkeit) |
Kategorie 1 |
Achtung |
![GHS hazard pictograms]() src="/GHS08.jpg" width="20" height="20" /> |
|
|
| Sicherheit |
|
IPI 145 Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
IPI 145 is an 1,2-dihydroisoquinolin-1(2H)-one derivative and has been developed as a modulator of PI3 kinase.
Trademarks
Copiktra
IPI 145 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
IPI 145 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 173)Lieferanten
1201438-56-3()Verwandte Suche:
- IPI-145
- IPI-145 (INK-1197)
- IPI-145 INK197
- 8-Chloro-2-phenyl-3-[(1S)-1-(9H-purin-6-ylamino)ethyl]-1(2H)-isoquinolinone
- IPI-145, >=98%
- Duvelisib (IPI-145, INK1197)
- DUVELISIB (IPI-145)
- 1(2H)-Isoquinolinone, 8-chloro-2-phenyl-3-[(1S)-1-(9H-purin-6-ylamino)ethyl]-
- 8-Chloro-2-phenyl-3-[(1S)-1-(9H-purin-6-ylamino)ethyl]-1(2H)-isoquinolinone Duvelisib (IPI-145, INK1197)
- Duvelisib
INK 1197
- IPI 145
- IPI 145 (Duvelisib)
- IPI-145, INK 1197, Duvelisib
- IPI-145 INK197;DUVELISIB (IPI-145)
- IPI-14
- DUVELISIB (IPI-145, INK1197);IPI 145; IPI145
- IPI145; IPI 145; IPI-145. INK-1197; INK 1197; INK1197;DUVELISIB (IPI-145; INK1197)
- CS-680
- 8-chloro-2-phenyl-3-[(1s)-1-(7h-purin-6-ylamino)ethyl]isoquinolin-1-one
- IPI-145 (Duvelisib, INK1197)
- Duvelisib, 98%, a novel and selective PI3K δ/γ inhibitor
- DUVELISIB, 1201438-56-3, DUVELISIB [USAN], SURECN153543, UNII-610V23S0JI, IPI145, CHEMBL3039502, MOLPORT-028-600-025
- IPI 145 USP/EP/BP
- Duvelisib
- IPI-145, INK197,Duvelisib
- INK-1197,Phosphoinositide 3-kinase,IPI 145,IPI145,inhibit,Duvelisib,PI3K,INK 1197,Inhibitor
- Dosulepin Impurity 3 (Dosulepin EP Impurity C)
- Duensibu
- Duvelisib Impurity
- 1201438-56-3
- 201438-56-3
- reference inhibitors
- Inhibitors
